Furthermore, the inflammatory environment can influence protein aggregation and clearance mechanisms, potentially exacerbating the accumulation of pathogenic protein species characteristic of various neurodegenerative disorders, such as amyloid beta in Alzheimer’s disease or alpha-synuclein in Parkinson’s disease. This evidence concerns the gene SNCA and early-onset autosomal dominant Alzheimer disease.